mutLBSgeneDB

mutLBSgeneDB
mutated Ligand Binding Site gene DataBase

Home

Download

 Statistics

Help

About Us

Bioinformatics and Systems Medicine Laboratory Bioinformatics and Systems Medicine Laboratory

Gene Summary

Ligand Binding Site Mutation Information

Protein Structure Related Information

Gene Expression and Gene-Gene Network

Phenotype Information

Pharmacological Information

Conservation Information for LBS

Gene summary for SH3GL2
Gene summary
Basic gene Info.Gene symbolSH3GL2
Gene nameSH3-domain GRB2-like 2
SynonymsCNSA2|EEN-B1|SH3D2A|SH3P4
CytomapUCSC genome browser: 9p22
Type of geneprotein-coding
RefGenesNM_003026.3,
DescriptionEndophilin A1 BAR domainSH3 domain protein 2ASH3 domain-containing GRB2-like protein 2bA335L15.1 (SH3-domain GRB2-like 2)endophilin-1endophilin-A1
Modification date20141207
dbXrefs MIM : 604465
HGNC : HGNC
Ensembl : ENSG00000107295
HPRD : 05125
Vega : OTTHUMG00000019601
ProteinUniProt: Q99962
go to UniProt's Cross Reference DB Table
ExpressionCleanEX: HS_SH3GL2
BioGPS: 6456
PathwayNCI Pathway Interaction Database: SH3GL2
KEGG: SH3GL2
REACTOME: SH3GL2
Pathway Commons: SH3GL2
ContextiHOP: SH3GL2
ligand binding site mutation search in PubMed: SH3GL2
UCL Cancer Institute: SH3GL2
Assigned class in mutLBSgeneDBC: This gene just belongs to mutLBSgenes.

Gene ontology having evidence of Inferred from Direct Assay (IDA) from Entrez
GO IDGO TermPubMed ID


Top
Ligand binding site mutations for SH3GL2

Cancer type specific mutLBS sorted by frequency
LBSAAchange of nsSNVCancer type# samples
D191D191NLUAD1
cf) Cancer type abbreviation. BLCA: Bladder urothelial carcinoma, BRCA: Breast invasive carcinoma, CESC: Cervical squamous cell carcinoma and endocervical adenocarcinoma, COAD: Colon adenocarcinoma, GBM: Glioblastoma multiforme, LGG: Brain lower grade glioma, HNSC: Head and neck squamous cell carcinoma, KICH: Kidney chromophobe, KIRC: Kidney renal clear cell carcinoma, KIRP: Kidney renal papillary cell carcinoma, LAML: Acute myeloid leukemia, LUAD: Lung adenocarcinoma, LUSC: Lung squamous cell carcinoma, OV: Ovarian serous cystadenocarcinoma, PAAD: Pancreatic adenocarcinoma, PRAD: Prostate adenocarcinoma, SKCM: Skin cutaneous melanoma, STAD: Stomach adenocarcinoma, THCA: Thyroid carcinoma, UCEC: Uterine corpus endometrial carcinoma.


Top
Protein structure related information for SH3GL2
Relative protein structure stability change (ΔΔE) using Mupro 1.1
Mupro score denotes assessment of the effect of mutations on thermodynamic stability.
  (ΔΔE<0: mutation decreases stability, ΔΔE>0: mutation increases stability)
: nsSNV at non-LBS: nsSNV at LBS

nsSNVs sorted by the relative stability change of protein structure by each mutation
Blue: mutations of positive stability change. and red : the most recurrent mutation for this gene.
LBSAAchange of nsSNVRelative stability change
D191D191N-0.54191835
(MuPro1.1: Jianlin Cheng et al., Prediction of Protein Stability Changes for Single-Site Mutations Using Support Vector Machines, PROTEINS: Structure, Function, and Bioinformatics. 2006, 62:1125-1132)

Structure image for SH3GL2 from PDB

Top
Differential gene expression and gene-gene network for SH3GL2
Differential gene expression between mutated and non-mutated LBS samples in all 16 major cancer types

Differential co-expressed gene network based on protein-protein interaction data (CePIN)
* Left PPI network was created from samples with mutations in the LBS of SH3GL2 and the right PPI network was created from samples without mutations in the LBS of SH3GL2. Only genes with p-value < 0.05 are shown.
Red circle: input gene. Orange circle: LBSgene. Blue circle: other gene.


Top

Top
Phenotype information for SH3GL2
Gene level disease information (DisGeNet)
Disease IDDisease name# PubMedAssociation type

Mutation level pathogenic information (ClinVar annotation)
Allele IDAA changeClinical significanceOriginPhenotype IDs

Top
Pharmacological information for SH3GL2
Gene expression profile of anticancer drug treated cell-lines (CCLE)
Heatmap showing the correlation between gene expression and drug response across all the cell-lines. We chose the top 20 among 138 drugs.We used Pearson's correlation coefficient.
Drug information targeting mutLBSgene (Approved drugs only)
Drug statusDrugBank IDNameTypeDrug structure

Gene-centered ligand-gene interaction network

Ligands binding to mutated ligand binding site of SH3GL2 go to BioLip
Ligand IDLigand short nameLigand long namePDB IDPDB namemutLBS


Top
Conservation information for LBS of SH3GL2
Multiple alignments for Q99962 in multiple species
LBSAA sequence# speciesSpecies
D191ALEKFDESKEI4Homo sapiens, Gallus gallus, Mus musculus, Rattus norvegicus
D191ARAKYEESLEE1Schizosaccharomyces pombe (strain 972 / ATCC 24843)
E195FDESKEIAESS4Homo sapiens, Gallus gallus, Mus musculus, Rattus norvegicus
E195YEESLEEFEDR1Schizosaccharomyces pombe (strain 972 / ATCC 24843)


Copyright © 2016-Present - The University of Texas Health Science Center at Houston
Site Policies | State of Texas